News About: Pharm. Industry
Pacific Pharm. to launch 6 sigma management innovative strategies.
Pacific Pharm. has launched so called 6 sigma management innovative program for the fist time in the pharmaceutical industry of Korea.
The company who has achieved to keep the business growth at a double digit is ...
Kuhnil to concentrate marketing on Gliadelwaper business.
Kuhnil announced that the company would concentrate a whole effort to the market development of Gliadelwaper, a first choice of drug for the malignant glioma patients.
The company said Gliadelwaper is a locally im...
Choongwae to nominate as a best company for labor management.
The Ministry of Labor nominated Choongwae as the 2005 best company for the labor culture in the pharmaceutical industry.
The Labor Culture Award system has been exercised since 1995 for the purpose of encouraging a...
Roche to warn a patent infringement against local companies.
F. Hoffmann La Roche AG advised for local companies not to infringe their patent of Carvetidil that was already registered in Korea, an exclusive therapeutic drug for congestive heart failure (CHF), asking them immedi...
Vitalhouse to market Elfocus through JUVitalhouse Inc. a bio-pharmaceutical company of Korea is selling Elfocus, a preparation containing a high purity of lutein, through JU, one of the largest internet shopping netw...
|
Neopharm's Atonyl to enter the Southeast Asian market.Neopharm Inc. (www.neopharm.co.kr) said that Atonil, an anti-atopic dermatitis drug, would be exported to Taiwan from Oct. this year under the distribution agreement with Youngs...
|
iBiopharm contracted business tie-up with a Japanese institute.
iBiopharm announced that an overall packaged cooperative agreement was signed on Sept. 8 with Dai ichi Chemical Pharmacokinetic Institute in Japan.
The two parties agreed active exchange and cooperation of services...
KRPIA highly welcome the treaty of transparent society.
The Korea Research Based Pharmaceutical Industry Association announced a high welcome for the treaty of transparency society on Sept. 13, by admitting it to express enthusiastic wills for the health and medical indust...
Novartis scientist visit to Korea for a cancer scientific seminar.
Dr. D. Young, the vice president responsible for the Novartis global clinical research on phase II/III studies, visited to Korea for the Asia-Pacific Scientific Seminar on Cancer in Seoul, staying 4 days.
Dr. Young...
Novartis Korea to finish a successful promotional campaign.Following a successful event of "Power Summit of Cardiovascular Internal Medical Doctors" working at general hospitals, Novartis Korea has satisfactorily achieved another campai...
|
